Even the mighty Novo Nordisk can't hold a candle to its peer in this area.Pharmaceutical giant Novo Nordisk (NVO 1.20%) is a terrific stock for many reasons. The company continues to deliver excellent financial results thanks to a lineup of medicines with incredibly fast-growing sales. Its pipeline also continues to produce more gems.Novo Nordisk's stock market performance has been incredible in recent years. It's hard to find a better growth stock among similarly sized drugmakers. However, it isn't a parti ...